|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Dec―13 |
Screening Asian Medicinal Plants for SARS-CoV-2 Inhibitors: A Computational Approach |
Hira Khalid, Iqra Ahmad, Asifa Sarfraz, Anwar Iqbal, Umar Nishan, Hanna Dib, et al. (+3) Riaz Ullah, Sheheryar Sheheryar, Mohibullah Shah |
2 |
[GO] |
2024―Nov―22 |
Uncovering the Therapeutic Potential of Propolis Extract in Managing Hyperinflammation and Long COVID-19: A Comprehensive Bioinformatics Study |
Isa Anshori, Donny Marcius, Putri Hawa Syaifie, Khalish Arsy Al Khairy Siregar, Luqman Abdan Syakuran, Muhammad Miftah Jauhar, et al. (+3) Adzani Gaisani Arda, Wervyan Shalannanda, Etik Mardliyati |
3 |
[GO] |
2024―Oct―23 |
Design, Synthesis, Biological Evaluation and Molecular Docking Studies of New Thiazolidinone Derivatives as NNRTIs and SARS-CoV-2 Main Protease Inhibitors |
Maria Fesatidou, Anthi Petrou, Athina Geronikaki |
4 |
[GO] |
2024―Aug―07 |
Discovery of a Highly Promising Disulfide Derivative Scaffold as Inhibitor of SARS-CoV-2 main protease |
Yin-Sui Xu, Yang Xiang, Le Zhai, Cheng Chen, Xiao-Rong Wu, Wei-Ya Chen, et al. (+4) Lu Liu, Mu-Han Zhao, Xiao-Long Liu, Ke-Wu Yang |
5 |
[GO] |
2024―Jul―08 |
Investigating the Potential of 2-Ethylbutyl-(Phenoxy)phosphoryl-D-Alaninate Against RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 |
Sandeep Yadav, Durgesh Kumar, Haritma Chopra, Ishita Bhatt, Ritu Gabba, Ankita Chaudhary, PRASHANT SINGH |
6 |
[GO] |
2024―Jun―05 |
Olive Leaf Extract Downregulates the Protein Expression of Key SARS-CoV-2 Entry Enzyme ACE-2, TMPRSS2, and Furin |
Abdurrahim Kocyigit, Ebru Kanimdan, Vildan Betul Yenigun, Zeynep Ozman, Fatmanur Babalı Balıbey, Ezgi Durmuş, Oznur Yasar |
7 |
[GO] |
2024―Mar―25 |
Exploring the Efficacy of Noncovalent SARS-CoV-2 Main Protease Inhibitors: A Computational Study Incorporating Design, ADMET, Molecular Dynamics Simulation, and DFT Analysis |
Fei Xiong, Yan-Jun Zhang, Hui-Ying Jiang, Zhong-Hua Wang |
8 |
[GO] |
2024―Mar―11 |
In Silico and In Vitro Screening of Some Pregnane Glycosides Isolated from Certain Caralluma Species as SARS-COV-2 Main Protease Inhibitors |
Essam Abdel-Sattar, Omnia Kutkat, Riham A. El-Shiekh, Mohamed K. El-Ashrey, Ahmed M. El Kerdawy |
9 |
[GO] |
2023―Nov―15 |
Molecular Design of Novel Inhibitor by TargetingIL-6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold-Hopping Techniques: A Dual Therapeutic Strategy for COVID-19 and Cancer |
Ishani Paul, Alankar Roy, Sujay Ray |
10 |
[GO] |
2023―Oct―27 |
Discovery of SARS-CoV-2 Inhibitors Featuring Novel Histidine α-Nitrile Motif |
Nilu V. Gone, M. Ghalib Enayathullah, Jessie Thomas, Parth Rathee, Rajeev Prabhakar, Kiran K. Bokara, Gangadhar J. Sanjayan |
11 |
[GO] |
2023―Oct―20 |
The Discovery of Novel Small Oxindole-based Inhibitors Targeting the SARS-CoV-2 Main Protease (Mpro) |
Lara Alzyoud, Radwa E. Mahgoub, Feda E. Mohamed, Bassam R. Ali, Juliana Ferreira, Wael M. Rabeh, et al. (+2) Noor Atatreh, Mohammad A Ghattas |
12 |
[GO] |
2023―Feb―06 |
Studies of cytotoxicity effects, SARS-CoV-2 main protease inhibition, and in silico interactions of synthetic chalcones. |
Octavio L. Guterres Fernandes, Tiago Tizziani, Bibiana P. Dambrós, Natália Ferreira de Sousa, Carime L. Mansur Pontes, Layzon A. L. da Silva, et al. (+7) Luiz A. Escorteganha Pollo, Francisco F. de Assis, Marcus T. Scotti, Luciana Scotti, Antonio L. Braga, Mario Steindel, Louis Pergaud Sandjo |
13 |
[GO] |
2023―Jan―04 |
A drug repurposing approach to identify therapeutics by screening pathogen box exploiting SARS-CoV-2 main protease |
Rashmi Tyagi, Anubrat Paul, Krishna Kumar Ojha, V Samuel Raj, Aditya K Panda, Sunil Kumar, et al. (+2) Anurag Chaurasia, Manoj Kumar Yadav |
14 |
[GO] |
2022―Sep―20 |
The Efficacy of Traditional Medicinal Plants in Modulating the Main Protease of SARS-CoV-2 and Cytokine Storm |
Jomin Choe, Phaik Har Yong, Zhi Xiang Ng |
15 |
[GO] |
2022―Feb―25 |
Isolation of thioinosine and butanolides from a Terrestrial Actinomycetes sp. GSCW-51 and their in-silico Studies for Potential against SARS-CoV-2 |
Muhammad Imran Tousif, Mamona Nazir, Muhammad Khalid, Shehla Perveen, Naseem Akhtar, Nosheen Farooq, et al. (+5) Muhammad Usman Khan, Rana Farhat Mehmood, Mohamad Fawzi Mahomoodally, Shabbir Muhammad, Saleh S. Alarfaji |
16 |
[GO] |
2021―Nov―23 |
Computational prediction of the potential target of SARS-CoV-2 inhibitor plitidepsin via molecular docking, dynamic simulations and MM-PBSA calculations |
Mahmoud El Hassab, Loah Hemeda, Zainab Elsayed, Sara Al-Rashood, Mohammed Amin, Hatem Abdel-Azizf, Wagdy Eldehna |